Multicenter phase II study of irinotecan plus weekly bolus 5-FU and high dose l-leucovorin for patients with metastatic colorectal cancer (OGSG 0201).

被引：0
|
作者：
Ishida, H [1 ]
Mishima, H [1 ]
Iwamoto, S [1 ]
Morimoto, T [1 ]
Kato, T [1 ]
Tsujinaka, T [1 ]
Furukawa, Y [1 ]
机构：
[1] Osaka Gastrointestinal Ctr, Chemotherapy Study Grp, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3718
引用
收藏
页码：298S / 298S
页数：1
相关论文
共 50 条
  • [1] Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancer
    Mishima, Hideyuki
    Ikenaga, Masakazu
    Ishida, Hideyuki
    Iwamoto, Shigenori
    Morimoto, Takashi
    Narahara, Hiroyuki
    Kato, Takeshi
    Tsujie, Masaki
    Kitai, Toshiyuki
    Fukunaga, Mutsumi
    Nakanish, Masayoshi
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    Taguchi, Tetsuo
    ANTICANCER RESEARCH, 2007, 27 (02) : 1003 - 1008
  • [2] Phase I study of CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic colorectal cancer
    Fujishima H.
    Kikuchi I.
    Miyanaga O.
    Ueda A.
    Baba E.
    Mitsugi K.
    Harada M.
    Nakano S.
    International Journal of Clinical Oncology, 2004, 9 (2) : 92 - 97
  • [3] Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients
    Baba, Eishi
    Fujishima, Hiromitsu
    Makiyama, Akitaka
    Uchino, Keita
    Tanaka, Risa
    Esaki, Taito
    Kusaba, Hitoshi
    Mitsugi, Kenji
    Nakano, Shuji
    Akashi, Koichi
    ADVANCES IN THERAPY, 2012, 29 (03) : 287 - 296
  • [4] Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients
    Eishi Baba
    Hiromitsu Fujishima
    Akitaka Makiyama
    Keita Uchino
    Risa Tanaka
    Taito Esaki
    Hitoshi Kusaba
    Kenji Mitsugi
    Shuji Nakano
    Koichi Akashi
    Advances in Therapy, 2012, 29 : 287 - 296
  • [5] Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
    Mitsukuni Suenaga
    Nobuyuki Mizunuma
    Daigo Shouji
    Eiji Shinozaki
    Satoshi Matsusaka
    Keisho Chin
    Masatoshi Oya
    Toshiharu Yamaguchi
    Tetsuichiro Muto
    Kiyohiko Hatake
    Journal of Gastroenterology, 2008, 43 : 842 - 848
  • [6] Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
    Suenaga, Mitsukuni
    Mizunuma, Nobuyuki
    Shouji, Daigo
    Shinozaki, Eiji
    Matsusaka, Satoshi
    Chin, Keisho
    Oya, Masatoshi
    Yamaguchi, Toshiharu
    Muto, Tetsuichiro
    Hatake, Kiyohiko
    JOURNAL OF GASTROENTEROLOGY, 2008, 43 (11) : 842 - 848
  • [7] A PHASE-I STUDY OF CPT-11, WEEKLY BOLUS 5-FU AND LEUCOVORIN IN PATIENTS WITH METASTATIC CANCER
    PARNES, HL
    TAIT, N
    CONLEY, B
    VANECHO, D
    ONCOLOGY REPORTS, 1995, 2 (06) : 1131 - 1134
  • [8] Appropriate schedule of oral tegafur / uracil (UFT) in combination with irinotecan (CPT-11) and bolus 5-FU / l-leucovorin (LV) in patients (pts) with metastatic colorectal cancer (MCRC): A phase I study
    Chayahara, N.
    Tamura, T.
    Miki, I.
    Okuno, T.
    Kamigaki, T.
    Nishisaki, H.
    Inoue, Y.
    Maeda, T.
    Sakaeda, T.
    Azuma, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] A phase II randomized study of Combined Infusional Leucovorin Sodium and 5-FU versus the Leucovorin Calcium followed by 5-FU both in combination with Irinotecan or Oxaliplatin in patients with metastatic colorectal cancer
    Bleiberg, H.
    Vandebroek, A.
    Deleu, I.
    Vergauwe, P.
    Kalantari, H. Rezaei
    D'Haens, G.
    Paesmans, M.
    Peeters, M.
    Efira, A.
    Humblet, Y.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2012, 75 (01): : 14 - 21
  • [10] A Multicenter Phase-II Study of 5-FU, Leucovorin and Oxaliplatin (FOLFOX6) in Patients with Pretreated Metastatic Colorectal Cancer
    Kato, Ken
    Inaba, Yoshitaka
    Tsuji, Yasushi
    Esaki, Taito
    Yoshioka, Akira
    Mizunuma, Nobuyuki
    Mizuno, Toshiro
    Kusaba, Hitoshi
    Fujii, Hirohumi
    Muro, Kei
    Shimada, Yasuhiro
    Shirao, Kuniaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (01) : 63 - 68
12345